Poland· PL-100201540
PoltechMIBI
A technetium (99mtc) sestamibi product containing technetii 99mtc succimeri solutio iniectabilis, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Technetium (99mtc) sestamibi is registered in 11 of 19 countries.
Countries holding a registration under ATC V09GA01 (technetium (99mtc) sestamibi), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Technetium (99mtc) sestamibi · ATC V09GA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Technetii 99mTc succimeri solutio iniectabilis
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09GA01
- ATC class
- Technetium (99mTc) sestamibi
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990326914
- gtin05909990326921
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09GA01
Technetium (99mtc) sestamibi, as other registers publish it.
- CzechiaCARDIO-SPECTMedi-Radiopharma Kft., Érd
- CzechiaCARDIO-SPECTMedi-Radiopharma Kft., Érd
- CzechiaCARDIO-SPECTMedi-Radiopharma Kft., Érd
- CzechiaCARDIO-SPECTMedi-Radiopharma Kft., Érd
- FinlandCardioliteLantheus MI UK Limited
- BelgiumCardioliteLantheus Medical Imaging
- CanadaDRAXIMAGE SESTAMIBIJUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
- BelgiumDraxmibi 1 mgDraximage
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4f0addc-3af4-4bc5-85e4-f8ed1f56f414 GET /v1/drugs/e4f0addc-3af4-4bc5-85e4-f8ed1f56f414?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "1 mg MIBI",
"packaging": "Lz ¦ Skasowane ¦ 5320\n1 zestaw \n05909990326914 ¦ Lz ¦ 16460\n3 fiol. liof.\n05909990326921 ¦ Lz ¦ 16462\n6 fiol. liof.",
"substance": "MIBI 1 mg",
"common_name": "Technetii 99mTc succimeri solutio iniectabilis",
"pl_product_id": "100201540",
"pozwolenie_nr": "03269",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about technetium (99mtc) sestamibi.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.